Influence of CYP2C8 polymorphisms on imatinib steady-state trough level in chronic myeloid leukemia and gastrointestinal stromal tumor patients

Verboom, M.C.; Visser, L.; Kouwen, S.; Swen, J.J.; Diepstraten, J.; Posthuma, W.F.; ... ; Wilms, E.B. (2017)

Article / Letter to editor

• chronic myeloid leukemia
• CYP2C8
• gastrointestinal stromal tumor
• imatinib
• pharmacogenetics
• pharmacokinetics
• single nucleotide polymorphism
• trough level

• All authors: Verboom, M.C.; Visser, L.; Kouwen, S.; Swen, J.J.; Diepstraten, J.; Posthuma, W.F.; Gelderblom, H.; Lammeren, D. van; Wilms, E.B.
• Date: 2017-06-30
• Journal: Pharmacogenetics and Genomics
• Volume: 27
• Issue: 6
• Pages: 223 - 226
• DOI: doi:10.1097/FPC.0000000000000278